Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 CAD | +2.69% | -0.86% | -12.91% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.91% | 79.83M | |
+30.38% | 78.41B | |
+3.25% | 25.42B | |
+7.09% | 8.86B | |
+13.45% | 8.7B | |
-30.05% | 6.99B | |
+17.95% | 5.34B | |
+2.27% | 4.15B | |
-8.00% | 3.86B | |
-7.07% | 3.42B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Transcript : HLS Therapeutics Inc., Q4 2020 Earnings Call, Mar 18, 2021